Providence Therapeutics: Funding, Investors & Team (Oct 2026)
Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat advanced ovarian cancer. The company's vaccine identifies tumor mutations and elicits an immune response against the tumor cells, enabling users to treat themselves and live life to the fullest. It aims to provide safe and effective medicines for people suffering from diseases with unmet medical needs. Scott Leary, Eric Marcusson, and Bradley Sorenson established the company in Toronto, Ontario in 2015.
Providence Therapeutics has raised $2.1M across 1 funding round on record, the most recent a Grant of $2.1M announced in Dec 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Providence Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2021.
Providence Therapeutics Funding Rounds
Providence Therapeutics Founders and Leadership Team
Contact details for the Providence Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Providence Therapeutics Funding Compared to Other Biotechnology Startups
Providence Therapeutics' latest round of $2.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Providence Therapeutics in Biotechnology and Toronto
Companies Similar to Providence Therapeutics
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
Providence Therapeutics Funding FAQs
What does Providence Therapeutics do?
Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat advanced ovarian cancer. The company's vaccine identifies tumor mutations and elicits an immune response against the tumor cells, enabling users to treat themselves and live life to the fullest. It aims to provide safe and effective medicines for people suffering from diseases with unmet medical needs. Scott Leary, Eric Marcusson, and Bradley Sorenson established the company in Toronto, Ontario in 2015.
How much funding has Providence Therapeutics raised?
Providence Therapeutics has raised $2.1M across 1 round on record. The most recent is a Grant of $2.1M announced in Dec 2021.
When did Providence Therapeutics last raise funding?
Providence Therapeutics' most recent funding round on record is a Grant of $2.1M, announced in Dec 2021.
Who is the CEO of Providence Therapeutics?
Brad Sorenson is listed as CEO at Providence Therapeutics.
Where is Providence Therapeutics headquartered?
Providence Therapeutics is based in Toronto, Ontario, Canada.
How many employees does Providence Therapeutics have?
Providence Therapeutics is in the 11-50 employee band.
How does Providence Therapeutics' funding compare to other Biotechnology startups?
Providence Therapeutics' latest round of $2.1M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Providence Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Providence Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.